Use of a novel CD11b/CD18 inhibitory agent in a C6-deficient rat to evaluate delayed xenograft rejection.
Johnson
E
E
Department of Surgery, University of Minnesota, Minneapolis, USA.
Leventhal
J
J
Dalmasso
A
A
Goswitz
J
J
Simone
P
P
Chen
S
S
Moyle
M
M
Matas
A
A
D000818:Animals; D018821:CD18 Antigens; D003183:Complement C6 / Q000172:deficiency*; D006023:Glycoproteins / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology*; D015801:Helminth Proteins / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016177:Macrophage-1 Antigen; D008565:Membrane Proteins; D051381:Rats; D011922:Rats, Mutant Strains; D014183:Transplantation, Heterologous / Q000276:immunology*
D018821:CD18 Antigens; D003183:Complement C6; D006023:Glycoproteins; D015801:Helminth Proteins; D007166:Immunosuppressive Agents; D016177:Macrophage-1 Antigen; D008565:Membrane Proteins; C086581:NIF protein, Ancylostoma caninum